Olivér Várhelyi: meetings with registered lobbies
Meetings 201–250 of 269, newest first. Published meetings between this office and the organisations in our lobbying lists
Public records onlyWhat this means
Every profile, record and figure comes from documents published by EU institutions, national authorities, courts, ethics bodies, the EU Transparency Register or established news outlets. We use no leaks, private data or anonymous tips. AI helps us gather and cross-check sources but never decides anyone's guilt: each record keeps its exact legal status and links to its source, so you can check it yourself
Registering is a legal transparency duty, not a sign of wrongdoing. Budgets and meetings show access, not influence on any particular decision
With the Commissioner
Published recordEuropean Federation of Pharmaceutical Industries and Associations
Site visit of UCB factory
With the Commissioner
Published recordEuropean Federation of Pharmaceutical Industries and Associations
Consumer protection dimension of specific dossiers
With the Cabinet
Published recordEuropean Federation of Pharmaceutical Industries and Associations
Site visit of UCB factory
With the Cabinet
Published recordEuropean Federation of Pharmaceutical Industries and Associations
Consumer protection dimension of specific dossiers
With the Commissioner
Published recordConsumer protection dimension of specific dossiers
With the Cabinet
Published recordConsumer protection dimension of specific dossiers
With the Cabinet
Published recordMerck Sharp & Dohme Europe Belgium SRL
Taking stock of pharma affairs and current EU-US relations
With the Commissioner
Published recordCEFIC - European Chemical Industry Council
Strengthening EU capacity in manufacturing active pharmaceutical ingredients (API)
With the Cabinet
Published recordCEFIC - European Chemical Industry Council
Strengthening EU capacity in manufacturing active pharmaceutical ingredients (API)
With the Cabinet
Published recordTo introduce Apple’s innovation in the field of health, and to exchange on the European Commission’s policy priorities
With the Cabinet
Published recordMerck Sharp & Dohme Europe Belgium SRL
Animal Health and preventive measures against infectious diseases
With the Cabinet
Published recordMerck Sharp & Dohme Europe Belgium SRL
Cardiovascular Action Plan, EU-US relations
With the Commissioner
Published recordExchange of views on the EU pharma and health policy matters
With the Cabinet
Published record• Intro to company • pharma legislation and CMA • UWWTP and health-specific policies (mental health, fertility, cancer and cardiovascular health)
With the Cabinet
Published recordIntroduce Haleon, Contribution of self-care sector to resilience of European healthcare systems and public health, - Opportunities for simplification in the healthcare sector
With the Cabinet
Published recordFood safety simplification
With the Commissioner
Published recordEuropean Federation of Pharmaceutical Industries and Associations
Exchange of views on the EU pharma policy
With the Cabinet
Published recordEuropean Federation of Pharmaceutical Industries and Associations
Exchange of views on the EU pharma policy
With the Commissioner
Published recordMerck Sharp & Dohme Europe Belgium SRL
EU pharmaceutical policy
With the Cabinet
Published recordMerck Sharp & Dohme Europe Belgium SRL
EU pharmaceutical policy
With the Commissioner
Published recordEU health policy
With the Cabinet
Published recordEU health policy
With the Commissioner
Published recordEuropean Confederation of Pharmaceutical Entrepreneurs
EU biotech policy
With the Cabinet
Published recordEuropean Confederation of Pharmaceutical Entrepreneurs
EU biotech policy
With the Cabinet
Published recordMerck Sharp & Dohme Europe Belgium SRL
Competitiveness of EU pharma sector
With the Commissioner
Published recordCompetitiveness of the European medical devices industry
With the Cabinet
Published recordCompetitiveness of the European medical devices industry
With the Commissioner
Published recordContribution of Vaccines industry to European health union priorities
With the Cabinet
Published recordContribution of Vaccines industry to European health union priorities
With the Cabinet
Published recordNutrition, food information
With the Cabinet
Published recordAnimal Welfare, Animal Health, Plant Health
With the Cabinet
Published recordAnimal Welfare, Animal Health, Plant Health
With the Cabinet
Published recordMerck Sharp & Dohme Europe Belgium SRL
Taking stock of ongoing pharmaceutical policy initiatives
With the Commissioner
Published recordAnimal health and welfare
With the Cabinet
Published recordAnimal health and welfare
With the Commissioner
Published recordEuropean Federation of Pharmaceutical Industries and Associations
Exchange of views on the EU pharma policy
With the Cabinet
Published recordEuropean Federation of Pharmaceutical Industries and Associations
Exchange of views on the EU pharma policy
With the Cabinet
Published recordEU health policy
With the Commissioner
Published recordExchange of views on the EU pharma policy
With the Cabinet
Published recordExchange of views on the EU pharma policy
With the Cabinet
Published recordWith the Cabinet
Published recordCEFIC - European Chemical Industry Council
Data protection under the Biocidal Products Regulation
With the Commissioner
Published recordMerck Sharp & Dohme Europe Belgium SRL
Meeting with representatives of AnimalhealthEurope
With the Cabinet
Published recordMerck Sharp & Dohme Europe Belgium SRL
Meeting with representatives of AnimalhealthEurope
With the Cabinet
Published recordDiscussion about EU priorities in the area of public health.
With the Cabinet
Published recordPriorities and challenges for the agri-food sector
With the Commissioner
Published recordEuropean Federation of Pharmaceutical Industries and Associations
Exchange of views on the EU health policy
With the Cabinet
Published recordEuropean Federation of Pharmaceutical Industries and Associations
Exchange of views on the EU health policy
With the Commissioner
Published recordEU health policy
With the Cabinet
Published recordEU health policy
Checked against sources on 11 Nov 2026